Institutional Manager · CIK 0001839435
Octagon Capital Advisors LP
NEW YORK, NY · File #028-20958
Latest AUM
$823.7M
Positions
27
Top-10 Concentration
67.4%
Filings
13
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Dec 202527 pos · $823.7M
- 13F HOLDINGS REPORTQ/E Sep 202527 pos · $659.8M
- 13F HOLDINGS REPORTQ/E Jun 202530 pos · $455.6M
- 13F HOLDINGS REPORT (Amended)Q/E Mar 202535 pos · $516.8M
- 13F HOLDINGS REPORTQ/E Mar 202535 pos · $516.8M
- 13F HOLDINGS REPORTQ/E Dec 202433 pos · $607.7M
- 13F HOLDINGS REPORTQ/E Sep 202442 pos · $642.9M
- 13F HOLDINGS REPORTQ/E Jun 202447 pos · $636.3M
- 13F HOLDINGS REPORTQ/E Mar 202457 pos · $834.4M
- 13F HOLDINGS REPORTQ/E Dec 202340 pos · $650.9M
- 13F HOLDINGS REPORTQ/E Sep 202341 pos · $718.7M
- 13F HOLDINGS REPORTQ/E Jun 202336 pos · $695.0M
- 13F HOLDINGS REPORTQ/E Mar 202332 pos · $642.2M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 756,000 | $102.0M | 12.38% |
| 2 | DIANTHUS THERAPEUTICS INC | DNTH | 2,416,667 | $99.6M | 12.09% |
| 3 | COGENT BIOSCIENCES INC | COGT | 2,350,000 | $83.5M | 10.13% |
| 4 | TAYSHA GENE THERAPIES INC | TSHA | 8,859,911 | $48.7M | 5.92% |
| 5 | GOSSAMER BIO INC | GOSS | 13,915,371 | $43.1M | 5.24% |
| 6 | KYMERA THERAPEUTICS INC | KYMR | 535,000 | $41.6M | 5.05% |
| 7 | ARRIVENT BIOPHARMA INC | AVBP | 1,971,054 | $39.7M | 4.81% |
| 8 | TREVI THERAPEUTICS INC | TRVI | 2,815,000 | $35.2M | 4.28% |
| 9 | OCULAR THERAPEUTIX INC | OCUL | 2,623,600 | $31.9M | 3.87% |
| 10 | MIND MEDICINE MINDMED INC | 60255C885 | 2,230,000 | $29.9M | 3.63% |
| 11 | CG ONCOLOGY INC | CGON | 600,000 | $24.9M | 3.02% |
| 12 | ALUMIS INC | ALMS | 2,530,700 | $24.7M | 3.00% |
| 13 | PALISADE BIO INC | PALI | 9,567,898 | $22.5M | 2.73% |
| 14 | CIDARA THERAPEUTICS INC | 171757206 | 100,000 | $22.1M | 2.68% |
| 15 | BIOAGE LABS INC | BIOA | 1,598,000 | $21.1M | 2.57% |
| 16 | KALVISTA PHARMACEUTICALS INC | KALV | 1,273,333 | $20.6M | 2.50% |
| 17 | RAPT THERAPEUTICS INC | 75382E208 | 574,000 | $19.4M | 2.36% |
| 18 | CENTESSA PHARMACEUTICALS PLC | CNTA | 750,000 | $18.8M | 2.28% |
| 19 | PHARVARIS N V | PHVS | 671,465 | $18.6M | 2.26% |
| 20 | LEXEO THERAPEUTICS INC | LXEO | 1,725,000 | $17.1M | 2.08% |